Development and Effectiveness Evaluation of a Community-Integrated Telemedicine Care Model for Patients with Noncommunicable Diseases through the Khlong Khuean District Health Board, Chachoengsao Province, Thailand
Keywords:
Telemedicine, Noncommunicable disease, Type 2 diabetes, Hypertension, Community-integrated careAbstract
Khlong Khuean District has a substantial of elderly people with noncommunicable diseases (NCDs), Going to the hospital for services creates a burden in terms of time, travel costs, and expenses for patients and their families. This mixed-methods research aimed to develop and assess the effectiveness of an integrated community-telemedicine care model that connecting Khlong Khuean hospital, subdistrict health promoting hospitals, village health volunteers, local administrative organizations, and the district-level quality of life development committee. The model was developed through three stakeholder meetings to design, review, refine, and finalize it with key adjustments namely: supporting DTX/BP, DTX quality control, using video consultation, and telepharmacy. Coordinating and preparing medications in advance, verifying patient identity, appointment reminders, and safety/referral pathways were emphasized. A prospective quasi-experimental controlled cohort was used to assess the model effectiveness. Fifty clinically stable type 2 diabetes and/or hypertension patients were enrolled in the experimental group while another 50 were assigned into the comparison group. Having assessment 3 times during 6 month trial at baseline (T0), month 3 (T3), and month 6 (T6). Both groups had the comparable basic characteristics. Regarding the key outcomes, it was found that the DM-based cohort group had HbA1c change from 5.93% to 6.26% in the experimental group and from 5.87% to 6.15% in the comparison group that was not significant different (p=0.750), and all patients had HbA1c <7.5% at T6. In the HT-based cohort group, the SBP decreased from 128.71 to 118.93 mmHg, compared to 134.67 to 133.04 mmHg of the comparison group, that the 8.16 mmHg difference was found (p=0.005). The total services cost of the experimental group was saved by 418.6 baht per visit compared to the comparison group, and the time spent was reduced by more than 3.72 hours per visit (p<0.001).In addition, no running out of medicines, ER visits, or hospitalizations due to NCD instability or switching from telemedicine to onsite/ER were found, and the experimental group had more satisfaction (p<0.001). The developed model was feasible for clinically stable NCD patients, preserved individualized glycemic control, improved systolic blood pressure, and reduced household time and financial burden. Interpretation should account for nonrandomized allocation and the 6 month follow up.
References
Choxi, H., VanDerSchaaf, H., Li, Y., & Morgan, E. (2022). Telehealth and the digital divide: Identifying potential care gaps in video visit use. Journal of Medical Systems, 46(9), 58.
Des Jarlais, D. C., Lyles, C., & Crepaz, N., TREND Group. (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement. American Journal of Public Health, 94(3), 361–366.
Diabetes Association of Thailand, The Endocrine Society of Thailand, Department of Medical Services, Ministry of Public Health, & National Health Security Office. (2024). Clinical practice guideline for diabetes 2023 (revised February 2024). (in Thai)
Hangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., et al. (2023). The effectiveness of telemedicine solutions for the management of type 2 diabetes: A systematic review, meta-analysis, and meta-regression. Journal of Diabetes Science and Technology, 17(3), 794–825. https://doi.org/10.1177/19322968211064633
Khlong Khuean Hospital. (2026). HOSxP NCD registry and Khlong Khuean District health service data, 2026 [Unpublished administrative data]. Chachoengsao, Thailand.
Kruse, C. S., Krowski, N., Rodriguez, B., Tran, L., Vela, J., & Brooks, M. (2017). Telehealth and patient satisfaction: A systematic review and narrative analysis. BMJ Open, 7(8), e016242.
Ministry of Public Health Thailand. (2017). eHealth strategy, Ministry of Public Health (2017–2026). Nonthaburi, Thailand.
Ministry of Public Health Thailand. (2021). Digital health strategy, Ministry of Public Health (2021–2025). Nonthaburi, Thailand.
Sakima, A., Akagi, Y., Akasaki, Y., Fujii, T., Haze, T., Kawakami-Mori, F., et al. (2025). Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: A systematic review and meta-analysis. Hypertension Research, 48(2), 478–491. https://doi.org/10.1038/s41440-024-01792-7
Şahin, E., Yavuz Veizi, B. G., & Naharci, M. I. (2024). Telemedicine interventions for older adults: A systematic review. Journal of Telemedicine and Telecare, 30(2), 305–319.
Snoswell, C. L., Taylor, M. L., Comans, T. A., Smith, A. C., Gray, L. C., & Caffery, L. J. (2020). Determining if telehealth can reduce health system costs: Scoping review. Journal of Medical Internet Research, 22(10), e17298.
Thai Hypertension Society. (2024). 2024 Thai guidelines on the treatment of hypertension. (in Thai)
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist. International Journal for Quality in Health Care, 19(6), 349–357.
United Nations Development Programme, World Health Organization, Ministry of Public Health Thailand, & United Nations Interagency Task Force on NCDs. (2021). Prevention and control of noncommunicable diseases in Thailand: The case for investment. Bangkok, Thailand.
von Elm, E., Altman, D. G., Egger, M., et al. (2007). The STROBE statement: Guidelines for reporting observational studies. The Lancet, 370(9596), 1453–1457.
World Health Organization. (2025a). Noncommunicable diseases. Geneva, Switzerland.
World Health Organization. (2025b). Global strategy on digital health 2020–2027. Geneva, Switzerland.
World Health Organization Thailand. (n.d.). Noncommunicable diseases: Health in all public policies for the prevention and control of NCDs. Bangkok, Thailand.
